Valproate add-on therapy for drug-resistant focal epilepsy

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and tolerability of valproate when used as add-on therapy for people with drug-resistant focal epilepsy.

This is a protocol.

Health topics:

Neurology > Epilepsy > Drugs for broad populations

Published:

20 July 2021

Authors:

Gianatsi M, Bresnahan R, Hill RA, Nevitt SJ, Marson AG, Tudur Smith C

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Gianatsi M, Bresnahan R, Hill RA, Nevitt SJ, Marson AG, Tudur Smith C. Valproate add-on therapy for drug-resistant focal epilepsy (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 7. Art. No.: CD014701. DOI: 10.1002/14651858.CD014701.